# EDGAR Filing Document

**Accession Number:** 0001618205
**File Stem:** 0001104659-23-019982
**Filing Date:** 2023-2
**Character Count:** 8388
**Document Hash:** 7204fb9e31a7c87b9586911e0cdaf46c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-019982.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001104659-23-019982

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20211205

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Strobeck Matthew
- **CENTRAL INDEX KEY:** 0001377832

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39577
- **FILM NUMBER:** 23620901

**MAIL ADDRESS:**
- **STREET 1:** C/O METABOLIX, INC.
- **STREET 2:** 21 ERIE STREET
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02139
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Birchview Fund LLC
- **CENTRAL INDEX KEY:** 0001603544
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39577
- **FILM NUMBER:** 23620902

**BUSINESS ADDRESS:**
- **STREET 1:** 688 PINE STREET
- **CITY:** BURLINGTON
- **STATE:** VT
- **ZIP:** 05401
- **BUSINESS PHONE:** 617

**MAIL ADDRESS:**
- **STREET 1:** 688 PINE STREET
- **CITY:** BURLINGTON
- **STATE:** VT
- **ZIP:** 05401
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Birchview Capital, LP
- **CENTRAL INDEX KEY:** 0001618205
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39577
- **FILM NUMBER:** 23620903

**BUSINESS ADDRESS:**
- **STREET 1:** 688 PINE STREET, SUITE D
- **STREET 2:** C/O BIRCHVIEW CAPITAL
- **CITY:** BURLINGTON
- **STATE:** VT
- **ZIP:** 05401
- **BUSINESS PHONE:** 802-923-3826

**MAIL ADDRESS:**
- **STREET 1:** 688 PINE STREET, SUITE D
- **STREET 2:** C/O BIRCHVIEW CAPITAL
- **CITY:** BURLINGTON
- **STATE:** VT
- **ZIP:** 05401
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AZIYO BIOLOGICS, INC.
- **CENTRAL INDEX KEY:** 0001708527
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 474790334
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 12510 PROSPERITY DRIVE
- **STREET 2:** SUITE 370
- **CITY:** SILVER SPRING
- **STATE:** MD
- **ZIP:** 20904
- **BUSINESS PHONE:** 240-247-1143

**MAIL ADDRESS:**
- **STREET 1:** 12510 PROSPERITY DRIVE
- **STREET 2:** SUITE 370
- **CITY:** SILVER SPRING
- **STATE:** MD
- **ZIP:** 20904

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Birchview Capital, LP<br><sub>(Last) (First) (Middle)</sub><br>688 PINE STREET, SUITE D<br><sub>(Street)</sub><br>BURLINGTON, VT 05401<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>AZIYO BIOLOGICS, INC. [ AZYO ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2021-12-05 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Birchview Fund LLC<br><sub>(Last) (First) (Middle)</sub><br>688 PINE STREET, SUITE D<br><sub>(Street)</sub><br>BURLINGTON, VT 05401<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>AZIYO BIOLOGICS, INC. [ AZYO ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2021-12-05 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Strobeck Matthew<br><sub>(Last) (First) (Middle)</sub><br>688 PINE STREET, SUITE D<br><sub>(Street)</sub><br>BURLINGTON, VT 05401<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>AZIYO BIOLOGICS, INC. [ AZYO ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2021-12-05 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 1417923 | I | See footnotes<sup>(1)(2)(3)(4)</sup> |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of Birchview Fund, LLC.

(2) Birchview Fund, LLC acquired 1,134,905 of the shares. Matthew Strobeck personally acquired 165,094 of the shares and acquired an additional 117,924 of the shares in custodial accounts in his name (the "Strobeck Shares").

(3) Of the Strobeck Shares, all 283,018 of the Strobeck Shares were held in separately managed accounts ("SMA") for which Birchview Capital, LP provided investment advice.

(4) As the investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of all the 1,134,905 shares held by the Fund.

**Signature:** Birchview Capital, LP By: /s/ Matthew Strobeck Matthew Strobeck, Managing Member of Birchview Capital GP, LLC, General Partner of Birchview Capital, LP  
**Date:** 2023-02-13

**Signature:** Birchview Fund LLC By: /s/ Matthew Strobeck Matthew Strobeck, Managing Member of Birchview Partners LLC, Manager of Birchview Fund LLC  
**Date:** 2023-02-13

**Signature:** /s/ Matthew Strobeck Matthew Strobeck  
**Date:** 2023-02-13

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**